Genetic Differences in Dorsal Hippocampus Acetylcholinesterase Activity Predict Contextual Fear Learning Across Inbred Mouse Strains.

acetylcholinesterase fear conditioning genetics hippocampus learning

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2021
Historique:
received: 08 07 2021
accepted: 21 09 2021
entrez: 4 11 2021
pubmed: 5 11 2021
medline: 5 11 2021
Statut: epublish

Résumé

Learning is a critical behavioral process that is influenced by many neurobiological systems. We and others have reported that acetylcholinergic signaling plays a vital role in learning capabilities, and it is especially important for contextual fear learning. Since cholinergic signaling is affected by genetic background, we examined the genetic relationship between activity levels of acetylcholinesterase (AChE), the primary enzyme involved in the acetylcholine metabolism, and learning using a panel of 20 inbred mouse strains. We measured conditioned fear behavior and AChE activity in the dorsal hippocampus, ventral hippocampus, and cerebellum. Acetylcholinesterase activity varied among inbred mouse strains in all three brain regions, and there were significant inter-strain differences in contextual and cued fear conditioning. There was an inverse correlation between fear conditioning outcomes and AChE levels in the dorsal hippocampus. In contrast, the ventral hippocampus and cerebellum AChE levels were not correlated with fear conditioning outcomes. These findings strengthen the link between acetylcholine activity in the dorsal hippocampus and learning, and they also support the premise that the dorsal hippocampus and ventral hippocampus are functionally discrete.

Identifiants

pubmed: 34733190
doi: 10.3389/fpsyt.2021.737897
pmc: PMC8558262
doi:

Types de publication

Journal Article

Langues

eng

Pagination

737897

Informations de copyright

Copyright © 2021 Mooney-Leber, Zeid, Garcia-Trevizo, Seemiller, Bogue, Grubb, Peltz and Gould.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Psychopharmacology (Berl). 2005 Aug;181(1):145-52
pubmed: 15778881
Nat Rev Neurosci. 2013 Jun;14(6):383-400
pubmed: 23686171
Neuron. 2016 Jun 1;90(5):1057-70
pubmed: 27161525
Comp Med. 2014 Feb;64(1):4-12
pubmed: 24672832
Methods Find Exp Clin Pharmacol. 2000 Oct;22(8):609-13
pubmed: 11256231
Nucleic Acids Res. 2020 Jan 8;48(D1):D716-D723
pubmed: 31696236
Chem Res Toxicol. 2016 Sep 19;29(9):1381-92
pubmed: 27551784
Psychopharmacology (Berl). 1992;107(4):530-4
pubmed: 1603896
Neuropsychopharmacology. 2005 Dec;30(12):2135-43
pubmed: 15956997
Behav Neurosci. 2015 Feb;129(1):37-41
pubmed: 25546366
Stroke. 2014 Dec;45(12):e244-6
pubmed: 25378423
Mol Vis. 2015 Jul 31;21:811-27
pubmed: 26283863
J Neurosci Res. 2017 Mar;95(3):836-852
pubmed: 27704595
Nat Rev Neurosci. 2003 Feb;4(2):131-8
pubmed: 12563284
Br J Pharmacol. 2008 Mar;153 Suppl 1:S177-83
pubmed: 18246096
Behav Neurosci. 1992 Apr;106(2):274-85
pubmed: 1590953
Hippocampus. 1996;6(5):535-45
pubmed: 8953306
Neuroreport. 1997 Mar 24;8(5):1173-8
pubmed: 9175108
Neuron. 2010 Jan 14;65(1):7-19
pubmed: 20152109
Brain Struct Funct. 2013 Jan;218(1):59-72
pubmed: 22246100
Neuropsychopharmacology. 1999 Dec;21(6):731-44
pubmed: 10633479
Behav Neurosci. 2001 Aug;115(4):951-6
pubmed: 11508735
Eur Neuropsychopharmacol. 1999 Jun;9(4):323-7
pubmed: 10422893
Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):249-53
pubmed: 7667336
Pathol Int. 1999 Nov;49(11):921-37
pubmed: 10594838
Genes Brain Behav. 2016 Feb;15(2):231-42
pubmed: 26690560
Neurosci Lett. 2012 Jan 11;506(2):208-13
pubmed: 22100909
J Psychopharmacol. 2020 Dec;34(12):1449-1456
pubmed: 32854587
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10825-30
pubmed: 12149439
Eur J Neurosci. 2004 Feb;19(3):705-12
pubmed: 14984421
Pharmacol Biochem Behav. 2011 Sep;99(3):316-23
pubmed: 21624386
Brain Res. 1997 Aug 22;766(1-2):101-6
pubmed: 9359592
Nat Rev Neurosci. 2002 Feb;3(2):122-31
pubmed: 11836520
Brain Res. 2014 Apr 22;1559:1-10
pubmed: 24594018
Brain Res. 2008 May 19;1210:179-88
pubmed: 18417102
Hippocampus. 2001;11(4):371-6
pubmed: 11530841
Sci Rep. 2014 Jan 17;4:3738
pubmed: 24435246
Neuropsychopharmacology. 2011 Jan;36(2):529-38
pubmed: 20962768
Neuroscience. 1997 Oct;80(4):1087-99
pubmed: 9284062
Yakugaku Zasshi. 2005 Jul;125(7):549-54
pubmed: 15997211
Pharmacol Biochem Behav. 1983 Feb;18(2):189-93
pubmed: 6601278
Psychopharmacology (Berl). 2001 Mar 1;154(2):126-30
pubmed: 11314674
Neuropharmacology. 2011 Mar;60(4):617-25
pubmed: 21167848
J Pharmacol Exp Ther. 2011 Jul;338(1):125-33
pubmed: 21493754
Mol Pharmacol. 2005 Nov;68(5):1431-8
pubmed: 16120769
Behav Brain Res. 2003 Mar 18;140(1-2):97-106
pubmed: 12644283
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):2089-94
pubmed: 11172080
Toxicology. 2018 Dec 1;410:10-15
pubmed: 30172647
Synapse. 1989;3(2):129-35
pubmed: 2564704
Learn Mem. 2007 Mar 08;14(3):134-44
pubmed: 17351136
Am J Med Genet B Neuropsychiatr Genet. 2009 Jun 5;150B(4):502-7
pubmed: 18780301
J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):137-47
pubmed: 10071091
Behav Brain Res. 2011 Sep 30;223(1):53-7
pubmed: 21514327
Behav Genet. 2012 Jan;42(1):133-50
pubmed: 21822688
Nat Rev Neurosci. 2001 Apr;2(4):294-302
pubmed: 11283752
Int J Geriatr Psychiatry. 2001 Sep;16(9):852-7
pubmed: 11571763
Learn Mem. 2005 Jul-Aug;12(4):389-98
pubmed: 16077017
ILAR J. 2005;46(2):140-7
pubmed: 15775023
Sci Rep. 2018 Jan 22;8(1):1319
pubmed: 29358722
Neuropharmacology. 1973 Apr;12(4):291-6
pubmed: 4735767
Behav Brain Res. 1999 Jul;102(1-2):31-9
pubmed: 10403013
Behav Brain Res. 2015 Oct 1;292:95-101
pubmed: 26051817
Neuroreport. 2000 Jul 14;11(10):2265-9
pubmed: 10923683
Annu Rev Neurosci. 2001;24:897-931
pubmed: 11520922
Behav Neural Biol. 1988 Nov;50(3):255-74
pubmed: 3202811
Brain Res. 1977 Nov 18;136(3):475-86
pubmed: 922496
Neuroscience. 2004;129(3):575-82
pubmed: 15541879
N Engl J Med. 2012 Mar 8;366(10):893-903
pubmed: 22397651
Mamm Genome. 2001 Aug;12(8):651-6
pubmed: 11471061
Brain Res Bull. 2002 Jan 1;57(1):41-7
pubmed: 11827736
Behav Neurosci. 2014 Oct;128(5):588-93
pubmed: 24911319
Physiol Behav. 2012 Dec 5;107(5):649-62
pubmed: 22245067
Neurosci Lett. 1988 Nov 22;94(1-2):93-8
pubmed: 3071750
Nature. 2011 Sep 14;477(7364):289-94
pubmed: 21921910
Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9697-701
pubmed: 7568200
Neurobiol Learn Mem. 2008 Jan;89(1):61-9
pubmed: 17931914

Auteurs

Sean M Mooney-Leber (SM)

Department of Psychology, University of Wisconsin-Stevens Point, Stevens Point, WI, United States.

Dana Zeid (D)

Department of Biobehavioral Health, The Pennsylvania State University, State College, PA, United States.

Prescilla Garcia-Trevizo (P)

Department of Biobehavioral Health, The Pennsylvania State University, State College, PA, United States.

Laurel R Seemiller (LR)

Department of Biobehavioral Health, The Pennsylvania State University, State College, PA, United States.

Molly A Bogue (MA)

The Jackson Laboratory, Bar Harbor, ME, United States.

Stephen C Grubb (SC)

The Jackson Laboratory, Bar Harbor, ME, United States.

Gary Peltz (G)

Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Palo Alto, CA, United States.

Thomas J Gould (TJ)

Department of Biobehavioral Health, The Pennsylvania State University, State College, PA, United States.

Classifications MeSH